Liver Diseases  >>  sunitinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sunitinib / Generic mfg.
NCT00247676 / 2005-000525-30: An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Completed
2
37
Europe, RoW
Sunitinib (SU011248), SU011248, Sutent
Pfizer
Liver Neoplasms, Unresectable Hepatocellular Carcinoma
02/08
02/09
NCT00495625: Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Terminated
2
33
US
Sunitinib Malate, SU011248, Sutent
H. Lee Moffitt Cancer Center and Research Institute, Pfizer
Liver Cancer
12/10
12/10

Download Options